SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615219-21-000022
Filing Date
2021-03-08
Accepted
2021-03-08 16:30:17
Documents
7
Period of Report
2021-03-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K salarius-form8xkxclosing20.htm 8-K 26974
2 EX-1.1 salarius-ladenburgunderwri.htm EX-1.1 298356
3 EX-5.1 salarius-ex51legalopiniont.htm EX-5.1 5970
4 EX-99.1 slrxpricingprv2.htm EX-99.1 10614
5 EX-99.2 salariusclosingpressreleas.htm EX-99.2 15628
6 image_01.jpg GRAPHIC 28927
7 image_01b.jpg GRAPHIC 39936
  Complete submission text file 0001615219-21-000022.txt   453844
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 21722348
SIC: 2834 Pharmaceutical Preparations